Ethics panel chair: Johnson won’t influence whether Gaetz report released
Rep. Michael Guest (R-Miss.), the chair of the House Ethics Committee, said that House Speaker Mike Johnson (R-La.) won’t ...
Johnson, Greene hold ‘productive meeting’ as Speaker vote nears
Speaker Mike Johnson (R-La.) and Rep. Marjorie Taylor Greene (R-Ga.) gathered privately for a “productive” meeting last week, ...
After 50-0 defeat of his $300 million property tax hike, Mayor Brandon Johnson brokers a new deal
Mayoral aides and some Council members have agreed to cut the proposed increase in half as talks continue. The largest chunk ...
Speaker Johnson's 'epic' weekend with Trump shows strengths and limits of his power
There was House Speaker Mike Johnson walking behind President-elect Donald Trump's entourage into Saturday night's UFC fight ...
The New Republic on MSN13hOpinion
Watch: Mike Johnson Offers Bonkers Defense of Trump Cabinet’s Morals
An authoritarianism scholar sounded alarm bells that Donald Trump’s incoming Cabinet nominees will do far more than usher a ...
Johnson Development Services' Park Eight Place awarded Walkable Places designation
The former Halliburton campus will be Houston's fourth "Walkable Place," a designation that will help with developing the ...
Johnson's government funding timeline differs from other Republicans' plans
After a weekend spent with President-elect Donald Trump, House Speaker Mike Johnson laid out a tentative plan on Sunday to ...
Mike Johnson denies consulting with Trump on Matt Gaetz ethics report
GOP senators fret Trump will expend political capital getting scandal-plagued Gaetz through tough confirmation vote ...
Dwayne Johnson’s $200 million-plus Christmas pic opens to $34.1 million
The big budget, star-driven action comedy with Dwayne Johnson and Chris Evans sold $34.1 million in tickets in its first ...
Johnson & Johnson (JNJ) Management presents at Stifel 2024 Healthcare Conference (Transcript)
Stifel 2024 Healthcare Conference November 18, 2024 10:55 AM ETCompany ParticipantsMichael Bodner - Group President, ...
Business Insider19h
Johnson & Johnson announces results from ICONIC-LEADa Phase 3 study
Johnson & Johnson announced positive topline results from ICONIC-LEADa, a pivotal Phase 3 investigational study of icotrokinra, or JNJ-2113, the first targeted oral peptide that selectively blocks the ...
Reuters on MSN7h
J&J's oral skin disease drug meets main goals of late-stage study
Nov 18 (Reuters) - Johnson & Johnson's (JNJ.N), opens new tab oral drug for a type of skin condition met the main goals of ...